A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.

MLA

Kufner, Sebastian, et al. “A Meta-Analysis of Specifically Designed Randomized Trials of Sirolimus-Eluting versus Paclitaxel-Eluting Stents in Diabetic Patients with Coronary Artery Disease.” American Heart Journal, vol. 162, no. 4, Oct. 2011, pp. 740–47. EBSCOhost, https://doi.org/10.1016/j.ahj.2011.07.003.

APA

Kufner, S., de Waha, A., Tomai, F., Park, S.-W., Lee, S.-W., Lim, D.-S., Kim, M. H., Galloe, A. M., Maeng, M., Briguori, C., Dibra, A., Schömig, A., & Kastrati, A. (2011). A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease. American Heart Journal, 162(4), 740–747. https://doi.org/10.1016/j.ahj.2011.07.003

Chicago

Kufner, Sebastian, Antoinette de Waha, Fabrizio Tomai, Seong-Wook Park, Seung-Whan Lee, Do-Sun Lim, Moo Hyun Kim, et al. 2011. “A Meta-Analysis of Specifically Designed Randomized Trials of Sirolimus-Eluting versus Paclitaxel-Eluting Stents in Diabetic Patients with Coronary Artery Disease.” American Heart Journal 162 (4): 740–47. doi:10.1016/j.ahj.2011.07.003.